Kharlamova AD - Search Results

1

Mono- and Diamination of 4,6-Dichloropyrimidine, 2,6-Dichloropyrazine and 1,3-Dichloroisoquinoline with Adamantane-Containing Amines.

Kharlamova AD, Abel AS, Averin AD, Maloshitskaya OA, Roznyatovskiy VA, Savelyev EN, Orlinson BS, Novakov IA, Beletskaya IP. Kharlamova AD, et al. Molecules. 2021 Mar 29;26(7):1910. doi: 10.3390/molecules26071910. Molecules. 2021. PMID: 33805408 Free PMC article.

2

Polyoxa- and Polyazamacrocycles Incorporating 6,7-Diaminoquinoxaline Moiety: Synthesis and Application as Tunable Optical pH-Indicators in Aqueous Solution.

Kurashov IA, Kharlamova AD, Abel AS, Averin AD, Beletskaya IP. Kurashov IA, et al. Among authors: kharlamova ad. Molecules. 2023 Jan 4;28(2):512. doi: 10.3390/molecules28020512. Molecules. 2023. PMID: 36677571 Free PMC article.

3

Novel slow-binding reversible acetylcholinesterase inhibitors based on uracil moieties for possible treatment of myasthenia gravis and protection from organophosphate poisoning.

Saifina LF, Abdalla M, Gubaidullina LM, Zueva IV, Eltayb WA, El-Arabey AA, Kharlamova AD, Lenina OA, Semenov VE, Petrov KA. Saifina LF, et al. Among authors: kharlamova ad. Eur J Med Chem. 2023 Jan 15;246:114949. doi: 10.1016/j.ejmech.2022.114949. Epub 2022 Nov 24. Eur J Med Chem. 2023. PMID: 36462442

4

Specific inhibition of acetylcholinesterase as an approach to decrease muscarinic side effects during myasthenia gravis treatment.

Petrov KA, Kharlamova AD, Lenina OA, Nurtdinov AR, Sitdykova ME, Ilyin VI, Zueva IV, Nikolsky EE. Petrov KA, et al. Among authors: kharlamova ad. Sci Rep. 2018 Jan 10;8(1):304. doi: 10.1038/s41598-017-18307-9. Sci Rep. 2018. PMID: 29321572 Free PMC article.

5

Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatment.

Kharlamova AD, Lushchekina SV, Petrov KA, Kots ED, Nachon F, Villard-Wandhammer M, Zueva IV, Krejci E, Reznik VS, Zobov VV, Nikolsky EE, Masson P. Kharlamova AD, et al. Biochem J. 2016 May 1;473(9):1225-36. doi: 10.1042/BCJ20160084. Epub 2016 Feb 29. Biochem J. 2016. PMID: 26929400

6

6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.

Zueva IV, Semenov VE, Mukhamedyarov MA, Lushchekina SV, Kharlamova AD, Petukhova EO, Mikhailov AS, Podyachev SN, Saifina LF, Petrov KA, Minnekhanova OA, Zobov VV, Nikolsky EE, Masson P, Reznik VS. Zueva IV, et al. Among authors: kharlamova ad. Int J Risk Saf Med. 2015;27 Suppl 1:S69-71. doi: 10.3233/JRS-150694. Int J Risk Saf Med. 2015. PMID: 26639718

7

6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease.

Semenov VE, Zueva IV, Mukhamedyarov MA, Lushchekina SV, Kharlamova AD, Petukhova EO, Mikhailov AS, Podyachev SN, Saifina LF, Petrov KA, Minnekhanova OA, Zobov VV, Nikolsky EE, Masson P, Reznik VS. Semenov VE, et al. Among authors: kharlamova ad. ChemMedChem. 2015 Nov;10(11):1863-74. doi: 10.1002/cmdc.201500334. Epub 2015 Sep 28. ChemMedChem. 2015. PMID: 26412714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7 results

Search Page